hsd_id_Glycine_max_6848	XP_003544415.1; XP_003550377.1; XP_040866112.1; XP_040862172.1	286; 293; 296; 296	Pfam	PF00650, PF03765; PF00650, PF03765; PF00650, PF03765; PF03765, PF00650	CRAL/TRIO domain, CRAL/TRIO, N-terminal domain; CRAL/TRIO domain, CRAL/TRIO, N-terminal domain; CRAL/TRIO domain, CRAL/TRIO, N-terminal domain; CRAL/TRIO, N-terminal domain, CRAL/TRIO domain	IPR001251, IPR011074; IPR001251, IPR011074; IPR001251, IPR011074; IPR011074, IPR001251	CRAL-TRIO lipid binding domain, CRAL/TRIO, N-terminal domain; CRAL-TRIO lipid binding domain, CRAL/TRIO, N-terminal domain; CRAL-TRIO lipid binding domain, CRAL/TRIO, N-terminal domain; CRAL/TRIO, N-terminal domain, CRAL-TRIO lipid binding domain

>XP_003544415.1
MFHRWSNSHQQDQGSSELYAESKIKELKGVIGPLSGRSLTYCTDACFKRYLEARNWNVDKSKKMLEETLRWRSTYKPEEIRWHEVAMEGETGKLYRASFHDRQGRTVLILRPGMQNTTSMENQLRHLVYLLENAMLNLPPGQEQMSWLIDFTGWSITNNVPLKLARETINILQNHYPERLAIAFLYNPPRVFEAFWKIVKYFLDNKTFQKVKFVYPNNKDSVQVMKSYFDEENLPKELGGKSIMSYNHEEFSRLMVQDDLKCAAFWGSDGKLSNHIVNGNSASVLK
>XP_003550377.1
MFHRWSNSHQQDQGSSELCTESKIKELKGAIGPLSGRSLMYCTDSCFKRYLEARNWNVDKSKKMLEETLRWRSTYKPEEIRWHEVAIEGETGKLYRANFHDRQGRNVLILRPGMQNTTSMENQLRHLVYLLENAMLNLPPGQEQMSWLIDFTGWSITNNVPLKLARETINILQNHYPERLAIAFLYNPPRVFEAFWKIVKYFLDNKTFQKVKFVYPKNKDSVELMKSYFDEENLPKELGGKSIMSYNHDEFSRLMVQDDLKCAAFWGSDGKLSNHIANGQSPAVCNETPPEAC
>XP_040866112.1
MFLLRRQTQNHHENDSSYQDTKVAELKTALGPLSGRQLKYCTDACLRRYLEARNWNVDKTKKMLEETLEWRATYRPEEIRWAEIAHEGETGKVSRANFHDRHGRAVLIMRPGMQNTTSAEDNIRHLVYLLENAILNLSEGQEQMSWLIDFTGLSLSTNISVKTSRDIIHILQNHYPERLAIAFLYNPPRIFQAFWKAIRFFLDPNTVQKVKFVYPNNKDSVELMKSLFDMENLPSEFGGKTSLKYDHEEFSRLMTEDDVKTAKFWGLDEEPFNPPKKGHSGAEVAPEPVPVQAVVS
>XP_040862172.1
MFLLRRQTQNNQENDSSYQDTKVAELKTGLGPLSGRRLKYCTDACLRRYLEARNWNVDKAKKMLEETLKWRATYKPEEIRWAEIAHEGETGKVSRANFHDRLGRTVLIMRPGMQNTTSAEDNIRHLVYLLENAILNLSEGQEQMSWLIDFTGLSLSTNMSVKTSRDIIHILQNHYPERLAIAFMYNPPRIFQAFWKAIRFFLDPKTVQKVKFVYPNNKDSVELIKSLFPTENLPSEFGGKTSLNYDHEEFSRLMTEDDVKTAKFWGLDEKPFNPPKKGHSGAEVAPEPVPVEAVVS